DK413987A - Substitueret phenylamidforbindelse - Google Patents

Substitueret phenylamidforbindelse

Info

Publication number
DK413987A
DK413987A DK413987A DK413987A DK413987A DK 413987 A DK413987 A DK 413987A DK 413987 A DK413987 A DK 413987A DK 413987 A DK413987 A DK 413987A DK 413987 A DK413987 A DK 413987A
Authority
DK
Denmark
Prior art keywords
phenylamide compound
substituted phenylamide
substituted
compound
phenylamide
Prior art date
Application number
DK413987A
Other languages
English (en)
Other versions
DK169404B1 (da
DK413987D0 (da
Inventor
Peter Thaddeus Gallagher
Terence Alan Hicks
Graham Walter Mullier
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of DK413987D0 publication Critical patent/DK413987D0/da
Publication of DK413987A publication Critical patent/DK413987A/da
Application granted granted Critical
Publication of DK169404B1 publication Critical patent/DK169404B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14Nitrogen atoms
    • C07D261/16Benzene-sulfonamido isoxazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DK413987A 1986-08-08 1987-08-07 Substitueret phenylamidforbindelse, fremgangsmåde til fremstilling deraf, anvendelse deraf til brug som farmaceutisk middel og farmaceutisk præparat indeholdende forbindelsen DK169404B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868619432A GB8619432D0 (en) 1986-08-08 1986-08-08 Pharmaceutical compounds
GB8619432 1986-08-08

Publications (3)

Publication Number Publication Date
DK413987D0 DK413987D0 (da) 1987-08-07
DK413987A true DK413987A (da) 1988-02-09
DK169404B1 DK169404B1 (da) 1994-10-24

Family

ID=10602473

Family Applications (1)

Application Number Title Priority Date Filing Date
DK413987A DK169404B1 (da) 1986-08-08 1987-08-07 Substitueret phenylamidforbindelse, fremgangsmåde til fremstilling deraf, anvendelse deraf til brug som farmaceutisk middel og farmaceutisk præparat indeholdende forbindelsen

Country Status (23)

Country Link
US (1) US4892963A (da)
EP (1) EP0257882B1 (da)
JP (1) JPS63239259A (da)
KR (2) KR880002823A (da)
CN (1) CN1015256B (da)
AR (2) AR244660A1 (da)
AT (1) ATE65494T1 (da)
AU (1) AU604737B2 (da)
CA (1) CA1317964C (da)
DE (1) DE3771611D1 (da)
DK (1) DK169404B1 (da)
EG (1) EG18269A (da)
ES (1) ES2031510T3 (da)
GB (1) GB8619432D0 (da)
GR (1) GR3002714T3 (da)
HU (1) HU197559B (da)
IL (1) IL83432A (da)
MX (1) MX174371B (da)
NZ (1) NZ221352A (da)
PH (1) PH22821A (da)
PT (1) PT85476B (da)
RU (1) RU1771472C (da)
ZA (1) ZA875813B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US5268382A (en) * 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
US4975462A (en) * 1988-07-29 1990-12-04 Bristol-Myers Company Antiarthritic α-arylcarbamoyl cyanoacetic acid derivatives
US5583150A (en) * 1989-08-18 1996-12-10 Alcon Laboratories, Inc. 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
US5108999A (en) * 1990-02-02 1992-04-28 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
JPH04211048A (ja) * 1990-03-05 1992-08-03 Mitsubishi Kasei Corp チオカルバモイルアセトニトリル誘導体
US5494911A (en) * 1990-05-18 1996-02-27 Hoechst Aktiengesellschaft Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf History of 3-cycloalkyl-prop-2-anamide
ES2079765T3 (es) * 1991-10-23 1996-01-16 Hoechst Ag Derivados de amidas de acido n-fenil-2-ciano-3-hidroxicrotonico y su utilizacion como medicamento con propiedad inmunomoduladora.
GB9200275D0 (en) * 1992-01-08 1992-02-26 Roussel Lab Ltd Chemical compounds
TW314467B (da) * 1993-03-31 1997-09-01 Hoechst Ag
WO1994024095A1 (en) * 1993-04-16 1994-10-27 Abbott Laboratories Immunosuppressive agents
GB9320299D0 (en) * 1993-10-01 1993-11-17 Roussel Lab Ltd Isoxazole derivatives
DK0787491T3 (da) * 1994-10-17 2000-10-16 Aventis Pharma Ltd Middel til forebyggelse og behandling af allergiske sygdomme af type I
DE19702988A1 (de) * 1997-01-28 1998-07-30 Hoechst Ag Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika
IL149792A0 (en) * 1999-12-16 2002-11-10 Teva Pharma Novel processes for making and a new crystalline form of leflunomide
ES2237553T3 (es) 2000-02-15 2005-08-01 Teva Pharmaceutical Industries Ltd. Procedimiento para la sintesis de leflunomida.
US6894184B2 (en) 2003-03-18 2005-05-17 Aventis Pharma Deutschland Gmbh Process for preparing 2-cyano-3-hydroxy-N-(phenyl)but-2-enamides
DE10311763A1 (de) * 2003-03-18 2004-10-07 Aventis Pharma Deutschland Gmbh Verfahren zur Herstellung von 2-Cyan-3-hydroxy-N-(phenyl)but-2-enamiden
JP2016537360A (ja) 2013-11-22 2016-12-01 ジェンザイム・コーポレーション 神経変性疾患を治療するための新規な方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DK545976A (da) * 1975-12-11 1977-06-12 Hoechst Ag Cyaneddikesyreanilidderivater fremgangsmade til deres fremstilling og midler der indeholder disse forbindelser
DE2654797A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Verfahren zur herstellung von isoxazolderivaten
DE2655009A1 (de) * 1976-12-04 1978-06-15 Hoechst Ag Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
FI71129C (fi) * 1979-06-11 1986-11-24 Ciba Geigy Ag Foerfarande foer framstaellning av farmaceutiskt aktiva alfakarbamoylpyrrolpropionitriler

Also Published As

Publication number Publication date
DK169404B1 (da) 1994-10-24
US4892963A (en) 1990-01-09
EG18269A (en) 1992-12-30
PT85476B (pt) 1990-06-29
ZA875813B (en) 1989-04-26
IL83432A (en) 1992-06-21
GR3002714T3 (en) 1993-01-25
HUT44523A (en) 1988-03-28
RU1771472C (ru) 1992-10-23
PT85476A (en) 1987-09-01
AR244660A1 (es) 1993-11-30
CA1317964C (en) 1993-05-18
GB8619432D0 (en) 1986-09-17
AR247876A1 (es) 1995-04-28
EP0257882A1 (en) 1988-03-02
CN1015256B (zh) 1992-01-01
KR880002815A (ko) 1988-05-11
PH22821A (en) 1989-01-19
MX174371B (es) 1994-05-11
EP0257882B1 (en) 1991-07-24
IL83432A0 (en) 1988-01-31
HU197559B (en) 1989-04-28
KR880002823A (ko) 1988-05-11
NZ221352A (en) 1989-10-27
DK413987D0 (da) 1987-08-07
ES2031510T3 (es) 1992-12-16
CN87105516A (zh) 1988-02-24
MX7668A (es) 1993-08-01
JPS63239259A (ja) 1988-10-05
DE3771611D1 (de) 1991-08-29
ATE65494T1 (de) 1991-08-15
AU604737B2 (en) 1991-01-03
AU7668187A (en) 1988-02-11

Similar Documents

Publication Publication Date Title
DE3751890T2 (de) Radionuklid-Antikörper-Verbindung
DK648687D0 (da) Quinolinforbindelse
DE3650706T2 (de) Substituierte Dicarboxypyridin-Verbindungen
DK85993D0 (da) 2-anilino-4-formyl-pyrimidinforbindelser
BA98296A (bs) Piperazinil-heterociklicna jedinjenja
DK164188C (da) Sammensat taetning
DK594687A (da) Pyrrolidinylthioforbindelser
DK413987A (da) Substitueret phenylamidforbindelse
DK492587D0 (da) Substituerede indolquinoxaliner
DK287688D0 (da) Heterocycliske forbindelser
PT84187A (pt) Novel compounds
DK227487A (da) Substituerede heterocycliske forbindelser
DK591887D0 (da) Antibiotiske forbindelser
PT86766A (pt) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds
DK290487D0 (da) Substituerede 3-amino-2-benzoylcyklohex-2-enoner
DK210487D0 (da) Substituerede benzimidazolderivater
IT1221792B (it) Composti metossimetilici
DK435186A (da) Somatostatinforbindelse
DK187686D0 (da) Benzisothiazol-s-oxidforbindelse
DK182487A (da) Octahydroquinolizinforbindelse
DE3789797T2 (de) Pyrimidinylphenyl-Ester-Verbindung.
DK375287D0 (da) Fungicid indeholdende substituerede thienylaminer
DK182587A (da) 3-diphenyl-substituerede octahydroindolizinforbindelser
KR880701715A (ko) 타우린- 형 화합물
DK45887A (da) Heterocykliske forbindelser

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed